Your browser doesn't support javascript.
loading
The dual role of non-selective beta-blockers in cirrhotic patients: How do we know when Dr Jekyll turns into Mr Hyde?
Thevenot, Thierry; Mouhat, Basile; Cervoni, Jean-Paul; Chopard, Romain.
Affiliation
  • Thevenot T; Department of Hepatology, University Hospital Besançon, Besançon, France.
  • Mouhat B; EA 4266 "Pathogens and inflammation, EPILAB", Université Bourgogne - Franche Comte, UFR SMP, Besançon, France.
  • Cervoni JP; Department of Cardiology, University Hospital Besançon, Besançon, France.
  • Chopard R; Department of Hepatology, University Hospital Besançon, Besançon, France.
Liver Int ; 41(5): 1166-1167, 2021 05.
Article in En | MEDLINE | ID: mdl-33342043
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adrenergic beta-Antagonists / Liver Cirrhosis, Alcoholic Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Adrenergic beta-Antagonists / Liver Cirrhosis, Alcoholic Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Liver Int Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article Affiliation country: France